The largest database of trusted experimental protocols

Sirtinol

Manufactured by Bio-Techne
Sourced in United Kingdom

Sirtinol is a small molecule inhibitor that selectively targets SIRT1, a member of the sirtuin family of NAD+-dependent protein deacetylases. It inhibits SIRT1 activity in a dose-dependent manner.

Automatically generated - may contain errors

5 protocols using sirtinol

1

Cell Colony Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated for 48 h with 50 μM sirtinol (Tocris), with camptothecin 30 nM for 24 h or pre‐treated with sirtinol for 24 h and then incubated with camptothecin and sirtinol for another 24 h as indicated. Cells were then washed three times with PBS and left to form colonies for 7–14 days. Colonies were stained with 0.1% (w/v) crystal violet in 20% (v/v) ethanol for counting. Results were normalised to plating efficiencies of untreated cells.
+ Open protocol
+ Expand
2

Sirtuin and AMPK Modulation of Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 24 h, to allow cell attachment, the medium was replaced and both the cell lines were incubated for 1 h with Sirtinol (Sirt, a sirtuins inhibitor; Tocris Bio-Techne, Minneapolis, MN, USA) or Compound C (CC, also known as dorsomorphin, an AMPK inhibitor; Merck KGaA, Darmstadt, Germany) at the concentration of 10 μM, or both, or their vehicle. After 1 h of incubation, Taurisolo® 100 μg/mL or vehicle (culture medium) was added and incubated for 1 h. After 1 h, the cells were incubated for 2 h with the pro-oxidant agent represented by H2O2 (200 μM for HASMCs and 100 μM for HUVECs). Cell viability was assessed using an aqueous solution of the cell proliferation reagent WST-1 (Roche, Basilea, Switzerland), (see Supplemental Materials).
+ Open protocol
+ Expand
3

Fly Head Acetylome Enrichment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fly samples were prepared as previously described 8, 57 with the following modifications. Briefly, 100 mg of male fly heads was homogenized in 1.4 ml homogenizing buffer (50 mM Tris–HCl pH 7.5, 500 mM NaCl, 1 mM EDTA, 0.1% NP‐40, and 20% glycerol) in the presence of 15 mM sodium butyrate and 60 μM of sirtinol (Tocris) and then added with 200 μl of 6 M urea/2 M thiourea. The proteins were digested for 4 h with 10 μg of Lys‐C (Wako) at 25°C, followed by overnight incubation (ON) with 300 μg trypsin (Worthington). Following the peptide isolation, peptide amount was measured by a nanodrop. Equal amount of peptides was enriched for acetylated peptides with 45 μl Ac‐K beads (ICP0388, Immunechem) overnight. Beads were washed 4× in PBS–Tween 0.1% followed by 4× in PBS. Finally, peptides were eluted with 125 μl of TFA 0.1% and were concentrated to a final volume of 17 μl. As input, 15 μl of each sample was taken before the enrichment for acetylated lysines and was diluted in TFA 0.1% and around 30 μg was desalted. From the resulting desalted samples, 3 μg was analyzed by mass spectrometry as described below.
+ Open protocol
+ Expand
4

Melatonin and ATP Modulate Inflammatory Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Melatonin and adenosine 5′-triphosphate (ATP) disodium hydrate were obtained from Sigma-Aldrich (St. Louis, USA) and Ultra-Pure LPS (from E. coli 0111: B4) was purchased from InvivoGen (San Diego, USA). Sirtinol was purchased from Tocris (Bristol, UK). Fetal bovine serum (FBS), RPMI 1640 cell culture media, L-Glutamine, penicillin/streptomycin, phosphate buffered saline (PBS), trypsin/EDTA were purchased from Biochrom (Berlin, Germany). All the antibodies used in experiments are given in Supplementary Table 1.
+ Open protocol
+ Expand
5

Inhibitors of Oncogenic Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitors of Skp2 (compound 25, alias SZL-P1-41; range 1.25–20 μM; Tocris, Bristol, UK), histone deacetylases (sirtinol; range 1.56–20 μM; Tocris), and neddylation (MLN4924, pevonedistat; range 0.04–2 μM; Active Biochem, Hong Kong) were first tested by MTT cell viability assay, as described previously [42 (link)]. PC3 and PC3 DR12 cells were treated with a concentration scale (10–40 μM) of compound 25 and incubated for 48 h. After 24 h of incubation of cells with 25 μM sirtinol, cycloheximide (50 μg/mL) was added for 2 and 4 h. PC3, PC3 DR12, and C4-2 and 22rv1 cells were also treated with 2 μM of MLN4924 (pevonedistat) and incubated for 24 h. LAPC4 cells were treated in the same way but with 1 μM of MLN4924. All experiments were performed at least three times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!